Nano-X Imaging vs Pulsenmore
NNOX and PLSM side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NNOX and PLSM compare
Pulsenmore grew revenue faster over the last twelve months (314% versus 15.4% for Nano-X Imaging).
Nano-X Imaging scores higher on the StockData Score (5 against 3 for Pulsenmore), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NNOX | PLSM |
|---|---|---|
| Size and price | ||
| Share price | $0.322 | $1.38 |
| Change, 1 year | −89.4% | – |
| Change, 5 years | −98.3% | – |
| Beta (5Y) | 1.37 | – |
| Employees | 197 | 63 |
| StockData Score | ||
| Total score | 5 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 1 (better) | 0 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 15.4% | 314% (better) |
| EPS growth (TTM) | – | −57.3% |
| Profitability | ||
| Gross margin | −98.2% | 84.2% (better) |
| Operating margin | −601% | – |
| Net margin | −576% | – |
| FCF margin | −346% | −82.5% (better) |
| Return on equity | −63.6% | – |
| Return on invested capital | −59.5% | – |
| Financial health | ||
| Debt / equity | 0.04 | – |
| Current ratio | 2.84 (better) | 1.84 |
| Piotroski F-score | 3 | – |
| Ownership | ||
| Held by institutions | 13.9% | 5.5% |
| Held by insiders | 10.4% | 31.8% |
| Insider net buying, 12 months | $190K (better) | $15.7K |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 9.3% | – |
Go deeper
- NNOX stock overview
- NNOX income statement
- NNOX valuation and score
- PLSM stock overview
- PLSM income statement
- PLSM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.